Matthew J. Walter

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-05-21

• U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in mice

  Leukemia · 2026-05-06

• Nonsense-Mediated RNA Decay Is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-Loop Accumulation and DNA Damage

  Cancer Research · 2026-04-09

• Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex

  American Journal of Hematology · 2026-03-29

• Exposure to Agent Orange and association with myelodysplastic syndromes

  Blood Advances · 2026-02-24

• Modeling the evolutionary dynamics of clonal hematopoiesis

  Nature Genetics · 2026-02-16 · 1 citations

• A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study

  Blood Advances · 2026-02-11 · 1 citations

• Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies

  Haematologica · 2026-02-05

• Clinical, genetic, and pathologic differences across race, ethnicity, and sex in patients with MDS and precursor conditions from the national MDS natural history study

  Blood · 2025-11-03

• A prospective Study of whole genome sequencing for genomic profiling and risk determination in MDS

  Blood · 2025-11-03

• Exposure to agent orange and risk of myelodysplastic syndromes

  Blood · 2025-11-03

• Development of synthetic introns for selective elimination of U2AF1 mutant MDS

  Blood · 2025-11-03

• Ivosidenib leads to durable responses in IDH1 mutated clonal cytopenias of undetermined significance: A phase II decentralized clinical trial

  Blood · 2025-11-03 · 2 citations

• IDH1/2-mutant clonal hematopoiesis: A novel driver of autoinflammatory disease

  Blood · 2025-11-03

• Mis-splicing of Mdm4 activates TRP53 and impairs HSPC growth in a mouse model of myelodysplastic syndromes

  Blood · 2025-11-03

• Sensitivity to ATR–CHK1 pathway inhibition in AML/MDS is enhanced by <i>SRSF2</i> mutations and reduced by RUNX1 lossPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-10-07

• Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid Cancers

  Journal of Molecular Diagnostics · 2025-09-27 · 1 citations

• PLENARY SESSION 05: MDS CLASSIFICATION IN 2025

  Leukemia Research · 2025-09-01

• Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy

  Nature Genetics · 2025-07-15 · 16 citations

• U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in micePreprint

  Research Square · 2025-05-07